Methods for delivering nucleic acid molecules into cells and assessment thereof

a nucleic acid and cell technology, applied in the field of nucleic acid delivery methods into cells, can solve the problems of unsatisfactory methods for delivering larger nucleic acid molecules, and achieve the effects of rapid, simple and accurate detection of delivery, and rapid quantification of differences in delivery efficiency

Inactive Publication Date: 2005-05-26
GLAXO GROUP LTD
View PDF23 Cites 22 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0028] Further provided are methods for monitoring delivery of nucleic acids into a cell. These methods permit the rapid and accurate measurement of nucleic acid transfer into cells, thus allowing for screening and optimizing the use of various delivery agents and protocols for delivery of any nucleic acid into any cell type, in vitro, ex vivo or in vivo. Further provided are methods to monitor delivery and expression of nucleic acids in a cell.
[0031] Because of the ease with which numbers of events are collected, the monitoring methods provided herein, particularly those based on flow cytometry techniques, provide a method for collection of nucleic acid molecule delivery data that is statistically superior to previous methods of evaluating nucleic acid molecules transfer. The positive values are instrument derived and therefore are not susceptible to judgement errors.
[0032] The monitoring methods provided herein permit the rapid, simple and accurate detection of delivery of small numbers of nucleic acid molecules into cells. Such small numbers may be sufficient for purposes of transgenesis, gene therapy, cellular protein production and other goals of gene transfer. The monitoring methods also make it possible to rapidly quantify differences in delivery efficiencies of differing delivery methods and thus facilitate the development and optimization of methods for the delivery of nucleic acid molecules, such as DNA, into cells.
[0033] These methods can also be used to optimize transfection efficiencies into cells for which no delivery protocol has been established or which are not easily transfected. These methods also permit rapid screening of delivery protocols and agents for their ability to enhance or permit delivery of nucleic acid molecules, such as DNA, of any size into a cell.

Problems solved by technology

These methods are not ideal for delivery of larger nucleic acid molecules.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods for delivering nucleic acid molecules into cells and assessment thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of Artificial Chromosomes

A. GFP Chromosome Contained in A9 Cell Line Plasmids

[0151] Plasmid pIRES-EGFP (see SEQ ID No. 13, plasmid obtained from Clontech, Calif., and is well known, see, e.g., U.S. Pat. Nos. 6,034,228, 6,037,133, 5,985,577, 5,976,849, 5,965,396, 5,976,796, 5,843,884, 5,962,265, 5,965,396; see, also, U.S. Pat. No. 4,937,190). This plasmid contains the internal ribosome entry site (IRES; Jackson (1990) Trends Biochem. 15:477-483; Jang et al. (1988) J. Virol. 62:2636-2643) of the encephalomyocarditis virus (ECMV) between the MCS and the enhanced green fluorescent protein (EGFP) coding region. This permits the gene of interest (cloned into the MCS) and the EGFP gene to be translated from a single bicistronic mRNA transcript. Plasmid pIRES2-EGFP is designed for selection, by flow cytometry and other methods, of transiently transfected mammalian cells that express EGFP and the protein of interest. This vector can also be used to express EGFP alone or to obt...

example 2

Preparation of Cationic Vesicles

[0186] Vesicles were prepared at a lipid concentration of 700 nmol / ml lipid (cationic lipid / DOPE 1:1) as follows. In a glass tube (10 ml) 350 nmol cationic lipid (SAINT-2) was mixed with 350 nmol dioleylphosphoethanolamine (DOPE), both solubilized in an organic solvent (Chloroform, Methanol or Chloroform / Methanol 1:1, v / v). Dioeylphosphatidylethanolamine (DOPE; Avanti Polar Lipids, Alabaster, Ala.) forms inverse hexagonal phases in a membrane and weakens the membrane. Other effectors that may be used are cis-unsaturated phosphaethanolamines, cis-unsaturated fatty acids, cholesterol. Cis-unsaturated phosphatidylcholines are less effective.

[0187] The solvent was evaporated under a stream of nitrogen (15 min / 250 μl solvent at room temperature). The remaining solvent was removed totally by drying the lipid for 15 min in a desiccator under high vacuum from a vacuum pump. To the dried mixture was added 1 ml ultrapure water. This was vortexed vigorously f...

example 3

Preparation of Cationic Vesicles Via Alcoholic Injection

[0188] In a glass tube (10 ml) 350 nmol cationic lipid (SAINT-2) was mixed with 350 nmol DOPE, both solubilized in an organic solvent (chloroform, methanol or chloroform / methanol 1 / 1). The solvent was evaporated under a stream of nitrogen (15 min / 250 μl solvent at room temperature). The remaining solvent was removed totally by drying the lipid for 15 min under high vacuum. This was then reconstituted in 100 μl pure ethanol.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
frequencyaaaaaaaaaa
timeaaaaaaaaaa
timeaaaaaaaaaa
Login to view more

Abstract

Methods for delivering nucleic acid molecules into cells and methods for measuring nucleic acid delivery into cells and the expression of the nucleic acids are provided. The methods are designed for introduction of large nucleic acid molecules, including artificial chromosomes, into cells, and are practiced in vitro and in vivo.

Description

RELATED APPLICATIONS [0001] This application is a continuation application of copending U.S. application Ser. No. 09 / 815,981, filed Mar. 22, 2001, published as U.S. appln. No. 2003-0003435, to GARY DE JONG and SANDRA LOUISE VANDERBYL, entitled “METHODS FOR DELIVERING NUCLEIC ACID MOLECULES INTO CELLS AND ASSESSMENT THEREOF.” The subject matter thereof is incorporated in its entirety by reference thereto. [0002] This application is related to U.S. application Ser. No. 09 / 815,979, filed Mar. 22, 2001 and published as U.S. appln. No. 2003-0059940, to GARY DE JONG, SANDRA LOUISE VANDERBYL, VOLKER OBERLE AND DIRK HOEKSTRA entitled “METHODS FOR DELIVERING NUCLEIC ACID MOLECULES INTO CELLS AND ASSESSMENT THEREOF.” The subject matter thereof is incorporated in its entirety by reference thereto.FIELD OF THE INVENTION [0003] The present invention relates to methods of delivering nucleic acid molecules into cells and methods for measuring nucleic acid delivery into cells and the expression of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K41/00C12N15/63C12N15/88
CPCA61K41/0047C12N15/88C12N15/63
Inventor DEJONG, GARYVANDERBYL, SANDRA
Owner GLAXO GROUP LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap